Applied UV

Applied UV, Inc. engages the development, acquisition and commercialization of technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets. It operates through following segments: Disinfection, Hospitality, and Corporate. The Disinfection segment designs, manufactures, assembles, and distributes automated disinfecting mirror systems for use in hospitals and other healthcare facilities. The Hospitality segment manufactures fine mirrors specifically for the hospitality industry. The Corporate segment represents expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The company was founded on February 26, 2019 and is headquartered in Mount Vernon, NY.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MOUNT VERNON, NY / ACCESSWIRE / August 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, August 17, 2021 at 8:30 am EDT to review its financial results. Second quarter 2021 financial results will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI.

Applied UV to Host Second Quarter 2021 Conference Call on August 17th

MOUNT VERNON, NY / ACCESSWIRE / July 29, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the that the underwriters of its 10.5% Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock") have exercised in full their over-allotment option to purchase an additional 72,000 shares of Series A Preferred Stock from Applied UV at a price to the public of $25.00 per share for gross proceeds of $1.8 million, prior to deducting underwriting discounts and commissions. After giving effect to the exercise of the over-allotment option, a total of 552,000 shares were sold in the offering, resulting in gross proceeds to Applied UV of $13.8 million.

Applied UV, Inc. Announces Full Exercise of Over-Allotment Option

Airocide® technology helps hospitals to remain open to protect patients, visitors and staff MOUNT VERNON, NY / ACCESSWIRE / July 21, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its Thailand distributor, V Eye Precision Ltd, has installed additional Airocide® units in Bangkok Metropolitan Administration Lat Krabang Hospital, to help create safer and cleaner environments for patients, visitors and staff. Applied UV continues to enhance its distributor relationships throughout Southeast Asia to meet the demand for its air and surface infection control products.

Applied UV Continues International Expansion with Airocide(R) Hospital Installation in Thailand

MOUNT VERNON, NY / ACCESSWIRE / July 19, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution agreement with Lootah Batta Water and Environment, LLC ("LBWE") for the distribution of the Airocide® consumer and commercial air purification systems within the United Arab Emirates ("UAE"). "We are immensely excited to be an exclusive distributor of Airocide products in the UAE", said Neeraj K.

Applied UV and Lootah Batta Water and Environment Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the United Arab Emirates

MOUNT VERNON, NY / ACCESSWIRE / July 16, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per share (the "Series A Preferred Stock"), at an initial public offering price of $25.00 per share, raising gross proceeds of $12.0 million before deducting underwriting discounts and other offering expenses. In connection with the offering, the Company has granted the underwriters a 45-day option to purchase up to an additional 72,000 shares of Series A Preferred Stock.

Applied UV, Inc. Announces Closing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

Applied UV (AUVI) has been struggling lately, but the selling pressure may be coming to an end soon.

Applied UV (AUVI) Sees Hammer Chart Pattern: Time to Buy?

MOUNT VERNON, NY / ACCESSWIRE / July 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per share (the "Series A Preferred Stock"), at an initial public offering price of $25.00 per share, raising gross proceeds of $12.0 million before deducting underwriting discounts and other estimated offering expenses. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions.

Applied UV, Inc. Announces Pricing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

MOUNT VERNON, NY / ACCESSWIRE / July 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced the Company's management team will participate in the Ladenburg Thalmann Virtual Healthcare Conference, held July 13-14, 2021. Applied UV's presentation is scheduled for Wednesday, July 14th at 12:30 pm ET.

Applied UV to Present at the Ladenburg Thalmann Virtual Healthcare Conference

Airocide® technology helps schools reopen and allow for the safe return to campus Distributor installation will serve as a prototype project for the expansion of the Airocide® solution into the school systems located in the EU MOUNT VERNON, NY / ACCESSWIRE / June 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its European distributor has installed Airocide® units in Verbier International School, a private boarding school located in Verbier, Switzerland to help create safer and cleaner environments for students and faculty throughout campus. Applied UV expects that this installation will serve as a prototype project for the expansion of the Airocide® solution into school systems located in the EU and UK.

Applied UV Continues International Expansion with Airocide(R) Installation in Swiss International School

Proceeds to be used for general corporate purposes, including new investments and potential future acquisitions MOUNT VERNON, NY / ACCESSWIRE / June 28, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced the commencement of an underwritten public offering of its 10.5% Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock"). Applied UV expects to grant the underwriters a 45-day option to purchase additional shares of the Series A Preferred Stock in connection with the offering.

Applied UV Announces Offering of Preferred Stock

Infection control technology company Applied UV Inc (NASDAQ: AUVI) has announced a  master distributor agreement for the United States with Facility Solutions Group (FSG), a lighting, electrical, and energy management services provider. The deal is for the SteriLumen portfolio of air and surface disinfection devices, including the Lumicide platform for infection control and Airocide products for air purification.

Applied UV Signs Distribution Agreement With FSG

MOUNT VERNON, NY / ACCESSWIRE / June 21, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of a Master Distributor agreement for the United States with FSG, one of the of the nation's largest lighting distributors and electrical contractors, for the SteriLumen portfolio of air and surface disinfection devices. "The disinfection market has been very significant for FSG with over $10 million dollars in sales in 2020, and we expect similar volume opportunities with Applied UV over the coming year," said Bernie Erickson, Executive Vice President and Director of Innovation for FSG.

Applied UV and FSG Sign Master Distributor Agreement

Infection control technology company Applied UV Inc (NASDAQ: AUVI) has announced receiving orders over $850 thousand for its Airocide consumer and commercial air purification systems. Applied received the order from 3Sixty Biopharmaceuticals, its exclusive distributor within Africa.

Applied UV Receives $850K Order For Air Purification System

Initial order is part of $3.5 million minimum first year purchase commitment of Airocide® systems MOUNT VERNON, NY / ACCESSWIRE / June 18, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that it has received orders in excess of $850,000 for its Airocide® consumer and commercial air purification systems from 3Sixty Biopharmaceuticals (Pty) Ltd. ("3Sixty"), the Company's exclusive distributor within the continent of Africa.

Applied UV Receives Initial Purchase Orders in Excess of $850,000 from 3Sixty Biopharmaceuticals, its Exclusive Distributor for Airocide(R) Air Purification Systems for the Continent of Africa

Applied UV (NASDAQ: AUVI) shares are trading higher after the company announced laboratory results confirming the SteriLumen Lumicide Ribbon kills SARS-CoV-2. SteriLumen Lumicide Ribbon is Applied UV's proprietary connected UVC disinfection platform for surface disinfection.

Why Shares Of Applied UV Are Trading Higher Today

With the world continuing to battle the Covid-19 pandemic, there has been a tremendous rise in hygiene-oriented expenditures by households and corporations alike. Many industries like hospitality have started showing signs of recovery and are ready to spend on making their premises as Covid-proof as possible.

Applied UV: Excellent Test Results for SteriLumen Against Covid-19

The stock price of Applied UV, Inc. (NASDAQ: AUVI) increased by over 7% during intraday trading. This is why it happened.

AUVI Stock Price Increases Over 7%: Why It Happened

Previously reported independent lab results confirmed killing OC43 human coronavirus ("OC43"), a common surrogate for SARS-CoV-2, the virus that causes COVID-19 MOUNT VERNON, NY / ACCESSWIRE / June 16, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an independent third-party laboratory confirming that the SteriLumen Lumicide™ Ribbon, Applied UV's proprietary connected UVC disinfection platform for surface disinfection, kills SARS-CoV-2 (COVID-19 Virus). The study was designed to determine the SteriLumen Lumicide™ Ribbon's effectiveness against the SARS-CoV-2 on hard surfaces.

Applied UV Announces Laboratory Results Confirm SteriLumen's Lumicide(TM) Ribbon Kills SARS-CoV-2 (COVID-19 Virus)

Distributor will provide fast access to a high growth market MOUNT VERNON, NY / ACCESSWIRE / June 3, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that today announced the signing of an exclusive distribution agreement with Viet My Instrument and Technology Joint Stock Company ("Distributor") for the distribution of the Airocide® consumer and commercial air purification systems in Vietnam. Under the terms of the agreement, the Distributor has agreed to a purchase commitment of a minimum of 100 Consumer and 45 Commercial Airocide® systems over the initial one-year term of the agreement.

Applied UV Sign Exclusive Distribution Agreement with Vietnam Distributor for Airocide(R) Air Purification Systems

Installation of Fifty Airocide® Systems Highlights Growing Demand for Better Air Quality at Live Indoor Events Leveraging industry recognition to expand market share in rapidly growing wine industry Airocide® Named Official Partner of "MUNDUS VINI" 2021 MOUNT VERNON, NY / ACCESSWIRE / June 2, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that it was chosen to supply the Airocide™ System of air purification technology for the 28th Grand International Wine Award "MUNDUS VINI" 2021. Airocide® is a leader in both the US and EU wine industry for its ability to protect stored and perishable aging wines from mold and other fungi and bacteria.

Applied UV's Airocide(R) System Installed in Judges Rooms to Protect Participants at the 28th Grand International Wine Award "MUNDUS VINI" 2021

60 Airocide® Units now operating in Colegio Santa Elena Installation is expected to be first of many as international expansion strategy accelerates Installation in school system follows recently awarded $3.5 million minimum first year purchase commitment to Applied UV from South Africa distributor MOUNT VERNON, NY / ACCESSWIRE / June 1, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that its distributor has installed 60 Airocide® units in Colegio Santa Elena, a private school located in Montevideo, Uruguay. Applied UV expects that this installation will serve as a prototype project for the expansion of the Airocide® solution into the school systems located in South America.

Applied UV's Airocide(TM) System Installed in Uruguayan School System

Disinfection technology player Applied UV Inc. ( AUVI , Financial) had a decent quarter and has started 2021 on a positive note. With enhanced infection prevention protocols being implemented across multiple industries, the company's surface disinfection and air purification products are becoming more and more relevant.

Applied UV: Disinfection Technology in Demand

Applied UV Inc (NASDAQ: AUVI) has signed an exclusive distribution agreement with 3Sixty Biopharmaceuticals (Pty) Ltd for Airocide consumer and commercial air purification systems within the continent of Africa. Under the terms of the agreement, 3Sixty will purchase upfront a minimum of $3.5 million of Airocide systems over the initial one-year term of the agreement.

Applied UV, 3Sixty Ink Distribution Pact For Airocide Air Purification Systems In Africa

$3.5 million minimum first year purchase commitment of Airocide ® systems MOUNT VERNON, NY / ACCESSWIRE / May 19, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution agreement with 3Sixty Biopharmaceuticals (Pty) Ltd. ("3Sixty") for the distribution of the Airocide® consumer and commercial air purification systems within the continent of Africa.

Applied UV and 3Sixty Biopharmaceuticals Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the Continent of Africa

MOUNT VERNON, NY / ACCESSWIRE / May 17, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced first quarter results for 2021. Q Saeed, Chief Executive Officer, commented, "Our business continues to show fundamental improvement that gives us confidence in our outlook for the remainder of 2021.

News for Applied UV Stock (AUVI)